MedPath

A Novel Score to Predict Risk of Symptomatic Intracerebral Hemorrhage

Completed
Conditions
Thrombectomy
Stroke
Intracerebral Hemorrhage
Interventions
Procedure: intra-arterial contrast enhanced Flat Detector CT
Registration Number
NCT04554368
Lead Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Brief Summary

This study sought to develop and validate a new risk stratification score (Henan predicting the risk of intracerebral hemorrhage score, Henan-PRIHS) based on intra-arterial contrast enhanced Flat Detector CT (IA-CEFDCT) to predict symptomatic intra-cerebral hemorrhage (sICH) after stroke thrombectomy.

Detailed Description

The Henan-PRIHS was developed from 95 patients who underwent IA-CEFDCT and MT for acute anterior stroke. Patients were classified as having one of three grades according to the presence of contrast filling within the occluded vascular territory. Grade 0 was normal or less contrast filling in affected hemisphere, grade 1 and 2 were small and medium-large area without contrast filling, respectively. The Youden index was used to determine the optimum no contrast filling area cutoff for defining grade 1 and 2. The score was subsequently validated in a different population of 208 patients and compared with three established scores.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. age ≥18 years,
  2. occlusion of internal carotid artery and/or middle cerebral artery (MCA) M1 or M2 segments confirmed by CTA or MRA or DSA,
  3. baseline National Institutes of Health Stroke Scale (NIHSS) score ≥ 4 points,
  4. MT was performed within 16 hours from stroke onset,
  5. baseline CT scan and IA-CEFDCT scan must be performed; 24 hours post-treatment CT scan was done and when the patient's neurological state had deteriorated.
Exclusion Criteria
  1. bilateral infarcts,
  2. history of hemorrhagic stroke,
  3. post-procedure ICH (including SAH) due to iatrogenic complications,
  4. missing clinical and demographic data,
  5. poor-quality IA-CEFDCT scans (i.e., motion artifact) that limited accurate identification of the region of interest. Bridge treatment (combined intravenous thrombolysis with MT) was not excluded from this study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
IA-CEFDCT groupintra-arterial contrast enhanced Flat Detector CT95 patients who underwent IA-CEFDCT and MT for acute anterior stroke.
Primary Outcome Measures
NameTimeMethod
Henan predicting the risk of intracerebral hemorrhage score5 days

Grade 0 was normal or less contrast filling in affected hemisphere, grade 1 and 2 were small and medium-large area without contrast filling, respectively.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shanghai 6th People's Hospital

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath